Global Health-Medanta jumps 3% on 'buy' rating from Motilal Oswal
"The company's growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix," Motilal Oswal Financial Services said.
Buy Bluedart Express; target of Rs 7840: Motilal Oswal
Motilal Oswal is bullish on Bluedart Express recommended buy rating on the stock with a target price of Rs 7840 in its research report dated September 21, 2023.
MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Closure of Trading Window
The Trading Window for dealing in securities of the Company will be closed from Saturday, September 30, 2023 for consideration and approval of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023. The Trading Window will open 48 hours after the declaration of the said financial results. MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Finance Committee of the Company at its meeting held on September 13, 2023 has allotted 27,216 Equity Shares of the Company under the various ESOP Schemes of the Company.
Subscribe to R R Kabel: Motilal Oswal
Motilal Oswal has come out with its report on R R Kabel. The research firm has recommended to Subscribe the ipo in its research report as on September 12 2023.
Motilal Oswal retains buy' on ICICI Bank; sees over 16% upside
The bank continues to see a strong growth in retail deposits and has successfully maintained a robust liability franchise, Motilal Oswal said. MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Analyst/ Investor(S) Meeting
Analyst/Investor(s) Meeting MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Acquisition
We are pleased to inform the Exchange that the Finance Committee of Motilal Oswal Financial Services Limited ("MOFSL"/"The Company") has at its Meeting held today i.e. September 01, 2023 has approved the proposal to make investment in Gufic Biosciences Limited by acquiring/subscribing to 33,33,000 equity shares having face value of Re. 1 each at Rs. 300/- per share for a consideration of Rs. 99.99 Crore, contributing to 3.32% of the post paid up capital of Gufic by wau of preferential issue. MOTILAL OSWAL FINANCIAL SERVICES LTD. - 532892 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to the captioned subject and pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform the Exchange that the Analyst / Institutional Investor(s) Meeting is scheduled to be held on Wednesday, September 06, 2023 in Elara Ashwamedh Conference at Mumbai. Kindly take the same on record.